Skip to main content
. 2018 Feb 27;10:34. doi: 10.3389/fnagi.2018.00034

Table 2.

Age- and gender-specific levels for urinary 8-oxodGsn/crea and 8-oxoGsn/crea (μmol/mol) derived from 1,228 normal subjects.

Age
1–10 years 11–20 years 21–30 years 31–40 years 41–50 years 51–60 years 61–70 years 71–80 years 81–90 years
8-oxodGsn
Male 2.01 ± 0.75 1.23 ± 0.52 1.30 ± 0.49 1.20 ± 0.48 1.23 ± 0.50 1.53 ± 0.61*,a,b 1.79 ± 0.88*,a,b 1.85 ± 0.92a 1.91 ± 0.89a
Female 1.91 ± 0.76 1.54 ± 0.62 1.31 ± 0.53 1.35 ± 0.67 1.33 ± 0.74 1.88 ± 0.79b 2.18 ± 0.96a,b 2.16 ± 1.10a 2.42 ± 0.83a
8-oxoGsn
Male 4.76 ± 1.45 1.48 ± 0.61 1.62 ± 0.40 1.70 ± 0.50 1.90 ± 0.54a 2.1 ± 0.77*,a,b 2.15 ± 0.66*,a 2.62 ± 0.89*,b 3.12 ± 1.2a,b
Female 5.05 ± 1.79 1.44 ± 0.40 1.53 ± 0.44 1.60 ± 0.50 1.76 ± 0.67b 2.3 ± 0.60b 2.88 ± 0.88a,b 2.99 ± 0.80a 2.9 ± 0.81a
*

p < 0.05compared to age matched female group.

a

p < 0.05 compared with gender matched 11–20 years group.

b

p < 0.05 compared with the gender matched neighboring younger group.